Seed VC · USA
Takeda Ventures is the corporate venture capital group founded in 2001 with the vision of generating disruptive technologies and therapeutic solutions for patients through venture-based investments, focusing on high-caliber, therapeutic, platform-based companies that complement Takeda's pipeline in areas aligned with its R&D pillars: Oncology, Rare Genetics, and other therapeutic areas.
Business models
deeptech_ip, biotech_therapeutics
Customer segments
Researchers
Geography
US, Europe, APAC
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Takeda Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Takeda Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Takeda Ventures is one of them — and we'll tell you exactly where they sit in your top 100.